مصطلحات الفهرس: drug safety, drug tolerability, dyspnea/si [Side Effect], febrile neutropenia/si [Side Effect], fever/si [Side Effect], human, infection/si [Side Effect], infestation/si [Side Effect], infusion related reaction/dt [Drug Therapy], infusion related reaction/si [Side Effect], monotherapy, nausea/si [Side Effect], neutropenia/si [Side Effect], pharmacodynamic parameters, pharmacokinetic parameters, pharmacological parameters, phase 3 clinical trial (topic), pneumonia/si [Side Effect], priority journal, pruritus/si [Side Effect], rigor/si [Side Effect], tachycardia/si [Side Effect], thrombocytopenia/si [Side Effect], tumor lysis syndrome/si [Side Effect], acalabrutinib/cb [Drug Combination], acalabrutinib/dt [Drug Therapy], bendamustine/dt [Drug Therapy], chlorambucil/ae [Adverse Drug Reaction], chlorambucil/cb [Drug Combination], chlorambucil/dt [Drug Therapy], clarithromycin/it [Drug Interaction], cyclophosphamide/cb [Drug Combination], cyclophosphamide/cm [Drug Comparison], cyclophosphamide/dt [Drug Therapy], fludarabine/cb [Drug Combination], fludarabine/cm [Drug Comparison], fludarabine/dt [Drug Therapy], hydrocortisone/dt [Drug Therapy], ibrutinib/cb [Drug Combination], ibrutinib/cm [Drug Comparison], ibrutinib/dt [Drug Therapy], obinutuzumab/cb [Drug Combination], obinutuzumab/dt [Drug Therapy], posaconazole/it [Drug Interaction], ritonavir/it [Drug Interaction], rituximab/ae [Adverse Drug Reaction], rituximab/cb [Drug Combination], rituximab/cm [Drug Comparison], rituximab/dt [Drug Therapy], venetoclax/ae [Adverse Drug Reaction], venetoclax/cb [Drug Combination], venetoclax/cm [Drug Comparison], venetoclax/it [Drug Interaction], venetoclax/dt [Drug Therapy], obinutuzumab/ae [Adverse Drug Reaction], abdominal pain/si [Side Effect], allogeneic hematopoietic stem cell transplantation, anemia/si [Side Effect], article, backache/si [Side Effect], cancer chemotherapy, cancer immunotherapy, cancer recurrence, chronic lymphatic leukemia/dt [Drug Therapy], chronic lymphatic leukemia/th [Therapy], diarrhea/si [Side Effect], drug efficacy, drug metabolism, drug potentiation, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27245
Future Oncology
Click here for full text options
LibKey Link

مصطلحات الفهرس: pruritus/si [Side Effect], randomized controlled trial (topic), rash/si [Side Effect], respiratory tract infection/si [Side Effect], second cancer/si [Side Effect], skin cancer/si [Side Effect], splenomegaly, subdural hematoma/si [Side Effect], thrombocytopenia/si [Side Effect], upper respiratory tract infection/si [Side Effect], urinary tract infection/si [Side Effect], very elderly, Waldenstroem macroglobulinemia/dt [Drug Therapy], bendamustine/dt [Drug Therapy], chlorambucil/dt [Drug Therapy], cisplatin/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], dexamethasone/dt [Drug Therapy], enoxaparin/cb [Drug Combination], hemoglobin/ec [Endogenous Compound], hydrocortisone/dt [Drug Therapy], ifosfamide/dt [Drug Therapy], immunoglobulin M/ec [Endogenous Compound], lomustine/dt [Drug Therapy], melphalan/dt [Drug Therapy], methylprednisolone/dt [Drug Therapy], myeloid differentiation factor 88/ec [Endogenous Compound], ofatumumab/dt [Drug Therapy], prednisolone/dt [Drug Therapy], prednisone/dt [Drug Therapy], rituximab/dt [Drug Therapy], zanubrutinib/ae [Adverse Drug Reaction], zanubrutinib/cb [Drug Combination], zanubrutinib/dt [Drug Therapy], zanubrutinib/tm [Unexpected Outcome of Drug Treatment], MYD88 gene, zanubrutinib/pv [Special Situation for Pharmacovigilance], adult, aged, anemia/si [Side Effect], arthralgia/si [Side Effect], article, atrial fibrillation/si [Side Effect], backache/si [Side Effect], basal cell carcinoma/si [Side Effect], bleeding/si [Side Effect], cellulitis/si [Side Effect], clinical article, constipation/si [Side Effect], contusion/si [Side Effect], coughing/si [Side Effect], decreased appetite/si [Side Effect], diarrhea/si [Side Effect], drug dose reduction, drug efficacy, drug safety, drug withdrawal, fatigue/si [Side Effect], female, fever/si [Side Effect], gene mutation, headache/si [Side Effect], hemoptysis/si [Side Effect], herpes zoster/si [Side Effect], human, hypertension/si [Side Effect], hyponatremia/si [Side Effect], infection/si [Side Effect], laceration/si [Side Effect], lymphadenopathy, male, monotherapy, multicenter study (topic), muscle spasm/si [Side Effect], neutropenia/si [Side Effect], opportunistic infection/si [Side Effect], overall survival, peripheral edema/si [Side Effect], phase 3 clinical trial (topic), pneumonia/si [Side Effect], priority journal, progression free survival, Article

URL: Click here for full text options
LibKey Link

مصطلحات الفهرس: ademetionine/dt [Drug Therapy], aminotransferase/ec [Endogenous Compound], bile salt export pump/ec [Endogenous Compound], colestyramine/dt [Drug Therapy], cytochrome P450 2D/ec [Endogenous Compound], cytochrome P450 3A4/ec [Endogenous Compound], dexamethasone/dt [Drug Therapy], estradiol/ec [Endogenous Compound], farnesoid X receptor/ec [Endogenous Compound], isoniazid/dt [Drug Therapy], multidrug resistance associated protein 2/ec [Endogenous Compound], multidrug resistance protein 3/ec [Endogenous Compound], progesterone/ec [Endogenous Compound], pyrazinamide/dt [Drug Therapy], rifampicin/ae [Adverse Drug Reaction], rifampicin/cm [Drug Comparison], rifampicin/dt [Drug Therapy], ursodeoxycholic acid/ct [Clinical Trial], ursodeoxycholic acid/cm [Drug Comparison], ursodeoxycholic acid/dt [Drug Therapy], rifampicin/ct [Clinical Trial], adult, article, Australia, bone pain/si [Side Effect], chill/si [Side Effect], controlled study, diarrhea/si [Side Effect], disease severity, drug efficacy, feasibility study, female, fetus hypoxia, fever/si [Side Effect], headache/si [Side Effect], heartburn/si [Side Effect], human, incidence, intrahepatic cholestasis/di [Diagnosis], intrahepatic cholestasis/dt [Drug Therapy], jaundice/si [Side Effect], laboratory test, major clinical study, maternal hypertension, monotherapy, morbidity, mortality, multicenter study, myalgia/si [Side Effect], neonatal intensive care unit, obstetric delivery, parallel design, preeclampsia, pregnancy, pregnancy diabetes mellitus, pregnancy outcome, premature labor, pruritus, quality control, randomized controlled trial, skin disease/si [Side Effect], stillbirth, stomach pain/si [Side Effect], transcription initiation, tuberculosis/dt [Drug Therapy], urticaria/si [Side Effect], vomiting/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28481
BMC Pregnancy and Childbirth
Click here for full text options
LibKey Link

مصطلحات الفهرس: female, gastrointestinal toxicity, gene frequency, gene mutation, genetic analysis, genetic association, human, intensive care, leukopenia/si [Side Effect], major clinical study, male, mortality, neutropenia, polymerase chain reaction, prevalence, pyrosequencing, retrospective study, sepsis, skin cancer/dt [Drug Therapy], thrombocytopenia/si [Side Effect], vomiting/si [Side Effect], capecitabine/dt [Drug Therapy], dihydropyrimidine dehydrogenase/ec [Endogenous Compound], fluorouracil/ae [Adverse Drug Reaction], fluorouracil/dt [Drug Therapy], spectrophotometer, BigDye XTerminator, BioRobot EZ1, NanoDrop 1000, mucosa inflammation/si [Side Effect], adjuvant therapy, adult, aged, anemia/si [Side Effect], article, blood toxicity, breast cancer/dt [Drug Therapy], cancer chemotherapy, cancer patient, diarrhea/si [Side Effect], digestive system cancer/dt [Drug Therapy], dihydropyrimidine dehydrogenase deficiency, DNA extraction, DNA sequencing, drug toxicity, febrile neutropenia/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28536
Annals of Gastroenterology
Click here for full text options
LibKey Link

مصطلحات الفهرس: laparotomy, leukocytosis/si [Side Effect], male, medication compliance, microscopy, missed diagnosis, pregnancy, tachycardia/si [Side Effect], thalassemia minor, young adult, C reactive protein, corticosteroid/iv [Intravenous Drug Administration], corticosteroid/pv [Special Situation for Pharmacovigilance], hydrocortisone/dt [Drug Therapy], hydrocortisone/iv [Intravenous Drug Administration], hydrocortisone/pv [Special Situation for Pharmacovigilance], mesalazine/ae [Adverse Drug Reaction], mesalazine/pv [Special Situation for Pharmacovigilance], metronidazole/iv [Intravenous Drug Administration], metronidazole/po [Oral Drug Administration], metronidazole/pv [Special Situation for Pharmacovigilance], paromomycin/pv [Special Situation for Pharmacovigilance], prednisolone/ae [Adverse Drug Reaction], prednisolone/pv [Special Situation for Pharmacovigilance], salazosulfapyridine/pv [Special Situation for Pharmacovigilance], Crohn disease, adult, aged, anemia/si [Side Effect], article, bloody diarrhea/si [Side Effect], case report, clinical article, computer assisted tomography, drug withdrawal, endoscopy, Entamoeba histolytica, female, gastroenterology, human, intestinal amebiasis/di [Diagnosis], intestinal amebiasis/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/26995
Click here for full text options
LibKey Link

مصطلحات الفهرس: drug safety, drug tolerability, dyspnea/si [Side Effect], febrile neutropenia/si [Side Effect], fever/si [Side Effect], human, infection/si [Side Effect], infestation/si [Side Effect], infusion related reaction/dt [Drug Therapy], infusion related reaction/si [Side Effect], monotherapy, nausea/si [Side Effect], neutropenia/si [Side Effect], pharmacodynamic parameters, pharmacokinetic parameters, pharmacological parameters, phase 3 clinical trial (topic), pneumonia/si [Side Effect], priority journal, pruritus/si [Side Effect], rigor/si [Side Effect], tachycardia/si [Side Effect], thrombocytopenia/si [Side Effect], tumor lysis syndrome/si [Side Effect], acalabrutinib/cb [Drug Combination], acalabrutinib/dt [Drug Therapy], bendamustine/dt [Drug Therapy], chlorambucil/ae [Adverse Drug Reaction], chlorambucil/cb [Drug Combination], chlorambucil/dt [Drug Therapy], clarithromycin/it [Drug Interaction], cyclophosphamide/cb [Drug Combination], cyclophosphamide/cm [Drug Comparison], cyclophosphamide/dt [Drug Therapy], fludarabine/cb [Drug Combination], fludarabine/cm [Drug Comparison], fludarabine/dt [Drug Therapy], hydrocortisone/dt [Drug Therapy], ibrutinib/cb [Drug Combination], ibrutinib/cm [Drug Comparison], ibrutinib/dt [Drug Therapy], obinutuzumab/cb [Drug Combination], obinutuzumab/dt [Drug Therapy], posaconazole/it [Drug Interaction], ritonavir/it [Drug Interaction], rituximab/ae [Adverse Drug Reaction], rituximab/cb [Drug Combination], rituximab/cm [Drug Comparison], rituximab/dt [Drug Therapy], venetoclax/ae [Adverse Drug Reaction], venetoclax/cb [Drug Combination], venetoclax/cm [Drug Comparison], venetoclax/it [Drug Interaction], venetoclax/dt [Drug Therapy], obinutuzumab/ae [Adverse Drug Reaction], abdominal pain/si [Side Effect], allogeneic hematopoietic stem cell transplantation, anemia/si [Side Effect], article, backache/si [Side Effect], cancer chemotherapy, cancer immunotherapy, cancer recurrence, chronic lymphatic leukemia/dt [Drug Therapy], chronic lymphatic leukemia/th [Therapy], diarrhea/si [Side Effect], drug efficacy, drug metabolism, drug potentiation, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27245
Future Oncology
LibKey Link

مصطلحات الفهرس: human, hypertension/si [Side Effect], lower respiratory tract infection/si [Side Effect], major clinical study, male, nausea/si [Side Effect], neutropenia/si [Side Effect], oropharynx pain/si [Side Effect], overall response rate, overall survival, petechia/si [Side Effect], phase 1 clinical trial, phase 2 clinical trial, pneumonia/si [Side Effect], priority journal, progression free survival, pruritus/si [Side Effect], pseudallescheriasis/si [Side Effect], rash/si [Side Effect], remission, sepsis/si [Side Effect], side effect/si [Side Effect], skin cancer/si [Side Effect], stomach adenocarcinoma/si [Side Effect], thrombocytopenia/si [Side Effect], treatment response, tumor lysis syndrome/si [Side Effect], upper respiratory tract infection/si [Side Effect], Waldenstroem macroglobulinemia/dt [Drug Therapy], hemoglobin/ec [Endogenous Compound], immunoglobulin M/ec [Endogenous Compound], zanubrutinib/ae [Adverse Drug Reaction], zanubrutinib/ct [Clinical Trial], zanubrutinib/dt [Drug Therapy], multicenter study, actinic keratosis/si [Side Effect], adult, aged, anemia/si [Side Effect], arthralgia/si [Side Effect], article, atrial fibrillation/si [Side Effect], backache/si [Side Effect], bacterial arthritis/si [Side Effect], basal cell carcinoma/si [Side Effect], bleeding/si [Side Effect], bronchiectasis/si [Side Effect], cellulitis/si [Side Effect], constipation/si [Side Effect], contusion/si [Side Effect], coughing/si [Side Effect], demography, diarrhea/si [Side Effect], disease exacerbation, drug efficacy, drug safety, drug withdrawal, epistaxis/si [Side Effect], falling, fatigue/si [Side Effect], female, follow up, gastroesophageal reflux/si [Side Effect], headache/si [Side Effect], hepatitis B/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/26861
Blood
Click here for full text options
LibKey Link

مصطلحات الفهرس: radioisotope, unclassified drug, vipivotide tetraxetan lutetium lu 177/ae [Adverse Drug Reaction], vipivotide tetraxetan lutetium lu 177/ct [Clinical Trial], vipivotide tetraxetan lutetium lu 177/cm [Drug Comparison], vipivotide tetraxetan lutetium lu 177/iv [Intravenous Drug Administration], vipivotide tetraxetan lutetium lu 177/pv [Special Situation for Pharmacovigilance], 2 flourine 18 fluoro 2 deoxy dextro glucose f 18, vipivotide tetraxetan lutetium lu 177/dt [Drug Therapy], aged, anemia/si [Side Effect], article, Australia, cancer screening, cancer therapy, castration resistant prostate cancer/dt [Drug Therapy], controlled study, diarrhea/si [Side Effect], dizziness/si [Side Effect], drug efficacy, drug safety, dry eye/si [Side Effect], dysgeusia/si [Side Effect], fatigue/si [Side Effect], foot pain/si [Side Effect], hair loss/si [Side Effect], hand pain/si [Side Effect], hematology, hematuria/si [Side Effect], human, insomnia/si [Side Effect], kidney function, leukopenia/si [Side Effect], liver function, male, metastasis, multicenter study, multiple cycle treatment, nausea/si [Side Effect], neuropathy/si [Side Effect], neutropenia/si [Side Effect], pain/si [Side Effect], patient participation, phase 2 clinical trial, positron emission tomography-computed tomography, priority journal, randomized controlled trial, rash/si [Side Effect], taste disorder/si [Side Effect], thrombocytopenia/si [Side Effect], treatment outcome, treatment response, vomiting/si [Side Effect], xerostomia/si [Side Effect], cabazitaxel/ae [Adverse Drug Reaction], cabazitaxel/ct [Clinical Trial], cabazitaxel/cm [Drug Comparison], cabazitaxel/iv [Intravenous Drug Administration], cabazitaxel/pv [Special Situation for Pharmacovigilance], gallium gozetotide ga 68, prostate specific antigen/ec [Endogenous Compound], Article

URL: The Lancet
Click here for full text options
LibKey Link

مصطلحات الفهرس: pruritus/si [Side Effect], randomized controlled trial (topic), rash/si [Side Effect], respiratory tract infection/si [Side Effect], second cancer/si [Side Effect], skin cancer/si [Side Effect], splenomegaly, subdural hematoma/si [Side Effect], thrombocytopenia/si [Side Effect], upper respiratory tract infection/si [Side Effect], urinary tract infection/si [Side Effect], very elderly, Waldenstroem macroglobulinemia/dt [Drug Therapy], bendamustine/dt [Drug Therapy], chlorambucil/dt [Drug Therapy], cisplatin/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], dexamethasone/dt [Drug Therapy], enoxaparin/cb [Drug Combination], hemoglobin/ec [Endogenous Compound], hydrocortisone/dt [Drug Therapy], ifosfamide/dt [Drug Therapy], immunoglobulin M/ec [Endogenous Compound], lomustine/dt [Drug Therapy], melphalan/dt [Drug Therapy], methylprednisolone/dt [Drug Therapy], myeloid differentiation factor 88/ec [Endogenous Compound], ofatumumab/dt [Drug Therapy], prednisolone/dt [Drug Therapy], prednisone/dt [Drug Therapy], rituximab/dt [Drug Therapy], zanubrutinib/ae [Adverse Drug Reaction], zanubrutinib/cb [Drug Combination], zanubrutinib/dt [Drug Therapy], zanubrutinib/tm [Unexpected Outcome of Drug Treatment], MYD88 gene, zanubrutinib/pv [Special Situation for Pharmacovigilance], adult, aged, anemia/si [Side Effect], arthralgia/si [Side Effect], article, atrial fibrillation/si [Side Effect], backache/si [Side Effect], basal cell carcinoma/si [Side Effect], bleeding/si [Side Effect], cellulitis/si [Side Effect], clinical article, constipation/si [Side Effect], contusion/si [Side Effect], coughing/si [Side Effect], decreased appetite/si [Side Effect], diarrhea/si [Side Effect], drug dose reduction, drug efficacy, drug safety, drug withdrawal, fatigue/si [Side Effect], female, fever/si [Side Effect], gene mutation, headache/si [Side Effect], hemoptysis/si [Side Effect], herpes zoster/si [Side Effect], human, hypertension/si [Side Effect], hyponatremia/si [Side Effect], infection/si [Side Effect], laceration/si [Side Effect], lymphadenopathy, male, monotherapy, multicenter study (topic), muscle spasm/si [Side Effect], neutropenia/si [Side Effect], opportunistic infection/si [Side Effect], overall survival, peripheral edema/si [Side Effect], phase 3 clinical trial (topic), pneumonia/si [Side Effect], priority journal, progression free survival, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28760
Blood Advances
LibKey Link

مصطلحات الفهرس: ademetionine/dt [Drug Therapy], aminotransferase/ec [Endogenous Compound], bile salt export pump/ec [Endogenous Compound], colestyramine/dt [Drug Therapy], cytochrome P450 2D/ec [Endogenous Compound], cytochrome P450 3A4/ec [Endogenous Compound], dexamethasone/dt [Drug Therapy], estradiol/ec [Endogenous Compound], farnesoid X receptor/ec [Endogenous Compound], isoniazid/dt [Drug Therapy], multidrug resistance associated protein 2/ec [Endogenous Compound], multidrug resistance protein 3/ec [Endogenous Compound], progesterone/ec [Endogenous Compound], pyrazinamide/dt [Drug Therapy], rifampicin/ae [Adverse Drug Reaction], rifampicin/cm [Drug Comparison], rifampicin/dt [Drug Therapy], ursodeoxycholic acid/ct [Clinical Trial], ursodeoxycholic acid/cm [Drug Comparison], ursodeoxycholic acid/dt [Drug Therapy], rifampicin/ct [Clinical Trial], adult, article, Australia, bone pain/si [Side Effect], chill/si [Side Effect], controlled study, diarrhea/si [Side Effect], disease severity, drug efficacy, feasibility study, female, fetus hypoxia, fever/si [Side Effect], headache/si [Side Effect], heartburn/si [Side Effect], human, incidence, intrahepatic cholestasis/di [Diagnosis], intrahepatic cholestasis/dt [Drug Therapy], jaundice/si [Side Effect], laboratory test, major clinical study, maternal hypertension, monotherapy, morbidity, mortality, multicenter study, myalgia/si [Side Effect], neonatal intensive care unit, obstetric delivery, parallel design, preeclampsia, pregnancy, pregnancy diabetes mellitus, pregnancy outcome, premature labor, pruritus, quality control, randomized controlled trial, skin disease/si [Side Effect], stillbirth, stomach pain/si [Side Effect], transcription initiation, tuberculosis/dt [Drug Therapy], urticaria/si [Side Effect], vomiting/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28481
BMC Pregnancy and Childbirth
LibKey Link